Literature DB >> 1356193

Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia.

A Antinori, R Murri, E Tamburrini, A De Luca, L Ortona.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1356193     DOI： 10.1016/0140-6736(92)92326-b

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.

Authors:  J Falloon; J Lavelle; D Ogata-Arakaki; A Byrne; A Graziani; A Morgan; M A Amantea; K Ownby; M Polis; R T Davey
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

2.  Pharmacokinetics of dapsone in human immunodeficiency virus-infected children.

Authors:  G Gatti; A Loy; R Casazza; F Miletich; M Cruciani; D Bassetti
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

3.  Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis.

Authors:  E M Carlin; R J Coker; R D Goldin; J R Harris
Journal:  Genitourin Med       Date:  1993-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.